CiteFacts · FDA Drug Shortages · FDA source
Ropivacaine Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Caplin Steriles, Ltd. | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) | Available | 06/10/2026 |
| Caplin Steriles, Ltd. | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) | Limited Availability | 06/10/2026 |
| Caplin Steriles, Ltd. | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) | Available | 06/10/2026 |
| Caplin Steriles, Ltd. | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) | Limited Availability | 06/10/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Unavailable | 08/06/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Available | 08/06/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Unavailable | 08/06/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Available | 08/06/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Available | 08/06/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Available | 08/06/2026 |
| Eugia US LLC | Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Unavailable | 08/06/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Available | 08/04/2026 |
| InfoRLife SA | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | Limited Availability | 08/18/2026 |
| InfoRLife SA | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | Unavailable | 08/18/2026 |
| InfoRLife SA | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | Available | 08/18/2026 |
| InfoRLife SA | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | Available | 08/18/2026 |
| InfoRLife SA | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | Available | 08/18/2026 |
| InfoRLife SA | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | Available | 08/18/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Available | 07/20/2026 |
Source facts
Grouped generic ingredient: Ropivacaine Hydrochloride Injection · 49 package records · Latest FDA row update: 08/18/2026
Therapeutic categories: Anesthesia
Dosage forms: Injection
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.